A 193-Amino Acid Fragment of the SARS Coronavirus S Protein Efficiently Binds Angiotensin-converting Enzyme 2

Abstract

The coronavirus spike (S) protein mediates infection of receptor-expressing host cells and is a critical target for antiviral neutralizing antibodies. Angiotensin-converting enzyme 2 (ACE2) is a functional receptor for the coronavirus (severe acute respiratory syndrome (SARS)-CoV) that causes SARS. Here we demonstrate that a 193-amino acid fragment of the S protein (residues 318-510) bound ACE2 more efficiently than did the full S1 domain (residues 12-672). Smaller S protein fragments, expressing residues 327-510 or 318-490, did not detectably bind ACE2. A point mutation at aspartic acid 454 abolished association of the full S1 domain and of the 193-residue fragment with ACE2. The 193-residue fragment blocked S protein-mediated infection with an IC(50) of less than 10 nm, whereas the IC(50) of the S1 domain was approximately 50 nm. These data identify an independently folded receptor-binding domain of the SARS-CoV S protein.

Cited by papers we hold 24

• PEDV: Insights and Advances into Types, Function, Structure, and Receptor Recognition · 2022
  No notice
• Perspectives and potential approaches for targeting neuropilin 1 in SARS-CoV-2 infection · 2021
  Not checked
• Human ACE2 receptor polymorphisms and altered susceptibility to SARS-CoV-2 · 2021
  No notice
• Chloroquine and hydroxychloroquine for combating COVID-19: Investigating efficacy and hypothesizing new formulations using Bio/chemoinformatics tools · 2020
  Not checked
• The SARS-CoV-2 Exerts a Distinctive Strategy for Interacting with the ACE2 Human Receptor · 2020
  No notice
• Subunit Vaccines Against Emerging Pathogenic Human Coronaviruses · 2020
  No notice
• COVID-19 in Human, Animal, and Environment: A Review · 2020
  Not checked
• The SARS-CoV-2 Spike Glycoprotein Biosynthesis, Structure, Function, and Antigenicity: Implications for the Design of Spike-Based Vaccine Immunogens · 2020
  No notice
• Neutralization of SARS-CoV-2 spike pseudotyped virus by recombinant ACE2-Ig · 2020
  No notice
• SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity · 2020
  No notice
• Possible Bat Origin of Severe Acute Respiratory Syndrome Coronavirus 2 · 2020
  No notice
• Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2 · 2020
  No notice
• Identification of SARS-CoV-2 Cell Entry Inhibitors by Drug Repurposing Using in silico Structure-Based Virtual Screening Approach · 2020
  No notice
• SARS-CoV-2 and Coronavirus Disease 2019: What We Know So Far · 2020
  No notice
• A candidate multi-epitope vaccine against SARS-CoV-2 · 2020
  No notice
• From SARS to MERS, Thrusting Coronaviruses into the Spotlight · 2019
  No notice
• Stabilized coronavirus spikes are resistant to conformational changes induced by receptor recognition or proteolysis · 2018
  Corrected
• Intranasal and oral vaccination with protein-based antigens: advantages, challenges and formulation strategies · 2015
  No notice
• A Truncated Receptor-Binding Domain of MERS-CoV Spike Protein Potently Inhibits MERS-CoV Infection and Induces Strong Neutralizing Antibody Responses: Implication for Developing Therapeutics and Vaccines · 2013
  Corrected
• Mechanisms of Host Receptor Adaptation by Severe Acute Respiratory Syndrome Coronavirus · 2012
  No notice

and 4 more

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.